HYAL1 and colorectal carcinoma: We first validated our CRC patient cohort by exploring the expression of two well-known CRC biomarkers, early diagnostic biomarker fibronectin 1 (FN1) and prognostic biomarker cell migration inducing hyaluronidase 1 (CEMIP) [16,17].